Endometriosis is commonly associated with chronic pelvic pain and its presentation varies between individuals. The only way to confirm the presence of endometriosis is via keyhole or open surgery. In the presence of hematuria, deep endometriotic infiltration needs to be considered. We share an interesting case highlighting the role of 18 F-fluorodeoxyglucose positron emission tomography-computed tomography in evaluating a posterior urinary bladder wall lesion and hypodense liver lesions in a middle-aged woman with presenting with frank hematuria in the background of treated cervical intraepithelial neoplasia and adenomyosis.
A 49-year-old Chinese female with a history of treatment for cervical intraepithelial neoplasia (CIN) III underwent hysterectomy for dysfunctional uterine bleeding and hematuria in a private medical center in December 2017 which was later histopathologically confirmed to be adenomyosis with no residual CIN on the specimen. She remained well until September 2018 when she presented to our hospital with abdominal discomfort and frank hematuria. Cystoscopy showed a cystic lesion invading to the urinary bladder mucosa which of which histopathological examination reported mullerianosis, but malignancy could not be excluded. The CA-125 was elevated at 102 ng/mL. The magnetic resonance imaging performed to delineate the lesion showed irregular enhancing mass which could represent endometrial cyst [ Figure 1a ]. In view of history of CIN III and the possibility of Mullerian carcinoma, contrast-enhanced computed tomography (CT) of the abdomen and pelvis performed in October 2018 showed an irregular lobulated soft tissue mass measuring 2.6 cm × 3.6 cm at the right posterolateral aspect of the urinary bladder wall and hypodense liver lesions in segment VII (0.9 cm × 1.0 cm) and VIII (1.1 cm × 0.8 cm). The actual prevalence of endometriosis worldwide is unknown as either key-hole or open surgery is required for definitive diagnosis. No noninvasive imaging modality is able to confirm endometriosis with enough accuracy to replace surgery.
[1] A study by Eisenberg et al. reported that the point prevalence of endometriosis was 10.8 per 1000 and an average annual incidence rate of 7.2 per 10,000 women in child-bearing
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For reprints contact: reprints@medknow.com age. [2] Endometriosis is a condition where the endometrial tissue is present outside the uterine cavity and causes pelvic inflammation. Although 18F-FDG is sensitive in detecting inflammatory changes, Fastrez et al. did not observe any hypermetabolic activity in relation to endometriosis using 18F-FDG PET/CT in their study of 10 patients. [3] On the contrary, Jeffry et al. reported their case where endometriosis was detected by 18F-FDG PET/CT. [4] In the study by Setubal et al. on nine patients, PET scans were reported to have no value as a major tool to evaluate deep endometriosis or other forms of endometriotic disease. [5] However, it is important to note that endometriosis is affected by the cyclical hormones and 18F-FDG PET/CT studies were performed at variable periods of the affected women's menstrual cycles. The common sites of endometriosis include ovaries, fallopian tubes, pelvic peritoneum, and pelvic ligaments, whereas atypical sites include the gastrointestinal tract, urinary bladder, ureter, abdominal wall, and pleura. [6] Patients with endometriosis at the urinary bladder frequently present with urinary frequency and if longstanding may present with hematuria due to the deep endometriotic infiltration. [7, 8] This is in keeping with our patient whose initial hematuria was overlooked. This case highlights the benefits of 18F-FDG PET/CT in our management planning, by excluding distant metastasis to the liver and identifying the nature of the soft tissue mass at the right posterolateral wall of the urinary bladder.
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